Recombinant Collagen is Expected to be the Next Hyaluronic Acid
- Chaileedo Press
- Sep 16, 2022
- 2 min read
Consumers are paying increased attention to anti-aging cosmetics with firming and anti-wrinkle effects.
According to Frost & Sullivan, Giant Biogene is the second largest professional skincare products company in China (by retail sales) in 2021, also, it has been the largest collagen professional skincare products company in China for 3 consecutive years. CHAILEEDO invited Duan Zhiguang, Senior Vice President of Giant Biogene, to talk about the future trends of cosmetics in China.
In his opinion, efficacy skincare products are one of the cosmetic sections that have received much attention in recent years. Its principle is to use active ingredients to repair the skin barrier and target skin problems. With consumer upgrading, consumer demand for skincare products is progressing toward a more personalized segmentation of efficacy. Ingredient formulations are becoming an increasingly significant observation indicator for consumers of efficacy skincare products, from the original pursuit of the concentration and variety of skincare ingredients to the pursuit of scientific proportioning systems and core ingredient technologies.
For the efficacy skincare market, the active ingredients and core ingredients can be said to be a crucial part of building a competitive barrier for the product. Collagen has always been a popular ingredient in skincare and has received much attention. According to the Skincare Industry Insight Report 2020, the annual discussion of collagen ranks first among skincare ingredients. So, will recombinant collagen become the next hyaluronic acid?
According to Duan Zhigang, "The main feature of hyaluronic acid is its hydrating and moisturizing effect, while that of collagen is skin repair, firming and anti-wrinkle. Currently, collagen can be divided into recombinant collagen and animal collagen."
According to Frost & Sullivan, the market size of recombinant collagen products in China is expected to increase from 18.5 billion yuan ($2.638 billion) in 2022 to 108.3 billion yuan ($15.441 billion) in 2027 at a CAGR of 42.4%.
With the advancement of synthetic biology technology and consumers' pursuit of efficacy, the market share of efficacy skincare products for collagen is expected to surpass that of hyaluronic acid in the future, said Zhigang Duan. Meanwhile, in the professional skincare market, the market share of recombinant collagen has already surpassed that of animal collagen.
CHAILEEDO also learned that in March this year, Giant Biogene's brand COLLGENE launched a new product "Human-like® LIFTACTIV WRINKLESS AND FIRMING ESSENCE" to seize the sensitive skin anti-aging section. It successfully entered the recombinant collagen anti-aging field by applying Human-like® recombinant collagen C5HA bionic combination technology to its products for the first time and presenting it publicly.
Duan Zhiguang is very optimistic about the future development of anti-aging cosmetics. He explained that consumers are paying more attention to anti-aging cosmetics with firming and anti-wrinkle effects. According to public research data, 53.2% and 23.2% of consumers in the age group of 26-35 and 18-25 will start to pay attention to anti-aging categories such as skin firming and anti-wrinkle in 2022 respectively, which indicates that consumers' anti-aging awareness is advanced. And in terms of skincare efficacy selection, 55.6% of them focus on anti-aging, firming, and anti-wrinkle efficacy, second only to hydration and moisturizing (57.8%).
On September 22, the 5th Conference on China’s Cosmetics Trends will be held in Hangzhou, China. CHAILEEDO will be live streaming the entire event, register now to book a live stream: https://www.chaileedo.com/events.
留言